JP Morgan Chase’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-129
Closed -$91 7832
2024
Q1
$91 Hold
129
﹤0.01% 6922
2023
Q4
$226 Hold
129
﹤0.01% 7036
2023
Q3
$186 Sell
129
-71
-36% -$178 ﹤0.01% 6848
2023
Q2
$520 Buy
200
+71
+55% +$212 ﹤0.01% 6543
2023
Q1
$0 Sell
129
-6,838
-98% -$28.8K ﹤0.01% 7345
2022
Q4
$12K Buy
6,967
+6,743
+3,010% +$17.9K ﹤0.01% 6004
2022
Q3
$1K Buy
224
+1
+0.4% +$6 ﹤0.01% 6394
2022
Q2
$2K Sell
223
-18,574
-99% -$152K ﹤0.01% 6317
2022
Q1
$276K Buy
18,797
+2,715
+17% +$36.3K ﹤0.01% 5012
2021
Q4
$254K Sell
16,082
-31,098
-66% -$747K ﹤0.01% 5221
2021
Q3
$1.51M Buy
47,180
+32,390
+219% +$1.14M ﹤0.01% 3991
2021
Q2
$614K Buy
14,790
+10,889
+279% +$447K ﹤0.01% 4572
2021
Q1
$198K Sell
3,901
-13,252
-77% -$693K ﹤0.01% 5156
2020
Q4
$557K Buy
17,153
+6,568
+62% +$93.1K ﹤0.01% 4309
2020
Q3
$119K Buy
10,585
+4,006
+61% +$46.4K ﹤0.01% 4611
2020
Q2
$87K Buy
+6,579
New +$85.7K ﹤0.01% 4629

Other funds holding DMTK

JP Morgan Chase's DMTK Position: Q2 2024 in Review

JP Morgan Chase sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 129 shares — an estimated $91 sold.

JP Morgan Chase first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $1.51M in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • JP Morgan Chase reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 129 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $91.
  • JP Morgan Chase first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • JP Morgan Chase's DermTech, Inc. Common Stock position peaked at $1.51M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.